Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biomerica Inc (NQ: BMRA )

6.410 USD +0.120 (+1.91%)
Streaming Delayed Price Updated: 12:51 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biomerica Inc

< Previous 1 2 3 4 Next >
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer
Biomerica, Inc. (Nasdaq: BMRA) announced that is has signed a three year agreement with Medline Industries for the distribution of Biomerica’s EZ Detect™ colorectal disease screening test designed to... 
From GlobeNewswire News Releases
Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ProQR Therapeutics N.V.... 
From GlobeNewswire News Releases
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud
Biomerica, Inc. (Nasdaq: BMRA) is pleased to announce that its first generation food intolerance product has been shown to alleviate symptoms of Ulcerative Colitis and improve quality of life in an... 
From GlobeNewswire News Releases
Biomerica Reports 1st Quarter Fiscal 2019 Financials
Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,272,870 for the three months ending August 31, 2018, compared to $1,444,483 for the same period in the previous year. 
From GlobeNewswire News Releases
Biomerica Announces Fiscal Year End 2018 Financial Results
Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2018 were $5,564,185 versus net sales of $5,791,670 in fiscal 2017. Net loss... 
From GlobeNewswire News Releases
Liolios 7th Annual Gateway Conference to Showcase 100 Leading Companies at the Four Seasons San Francisco September 5-6, 2018
Liolios’ Gateway Conference is back for its 7th year and will showcase approximately 100 public and private companies at the Four Seasons Hotel in San Francisco on September 5th and 6th. 
From GlobeNewswire News Releases
Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea
Biomerica, Inc. (Nasdaq:BMRA) announced today that the Korean Intellectual Property Office (KIPO) has issued a Notice of Allowance for a patent application covering Biomerica’s compositions, devices... 
From GlobeNewswire News Releases
Biomerica Announces First Patient Enrollment in Clinical Study for New Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy
Biomerica Inc. (NASDAQ:BMRA) today announced that the first patient has been enrolled in the randomized, double-blind, placebo-controlled, clinical trial of its new InFoods® diagnostic-guided therapy... 
From GlobeNewswire News Releases
Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board
Biomerica, Inc. (Nasdaq:BMRA) today announced that it has added Harry L. Leider, MD, MBA to its Strategic Advisor Board, which is chaired by Edward W. (Ned) Barnholt. 
From GlobeNewswire News Releases
Biomerica Announces Third Quarter Financial Results
Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for the period ended February 28, 2017. Sales for the three... 
From GlobeNewswire News Releases
Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer
Biomerica ships first order to Mexico 
From GlobeNewswire News Releases
Biomerica Announces Second Quarter Financial Results; Sales Up 12.7% for the Quarter
Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,613,636 for the three months ended November 30, 2017, compared to $1,432,206 for the same period in the previous year, an increase of 12.7%.... 
From GlobeNewswire News Releases
China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer
Biomerica, Inc. (Nasdaq:BMRA) announced the China Food and Drug Administration (CFDA) approval of the EZ Detect™ colorectal screening test designed to help identify the early warning signs of... 
From GlobeNewswire News Releases
Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)
Biomerica Inc. (NASDAQ:BMRA) today announced that the Company has signed definitive agreements with two of America’s leading research institutes to perform the clinical trials needed to validate the... 
From GlobeNewswire News Releases
Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019
Previously announced Korean deal valued at up to $8.5 million 
From GlobeNewswire News Releases
Biomerica Reports 1st Quarter Fiscal 2018 Financials
Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,444,483 for the three months ending August 31, 2017, compared to $1,410,110 for the same period in the previous year, an increase of 2.4%.... 
From GlobeNewswire News Releases
Analyst Sees >35% Upside in Shares of Biomerica, Inc.
From ACCESSWIRE
Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test
Biomerica Inc. (NASDAQ:BMRA) today announced that the Company has commenced clinical studies to evaluate the performance of its new and proprietary Helicobacter pylori (H. pylori) test. 
From GlobeNewswire News Releases
Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year
Biomerica, Inc. (Nasdaq:BMRA), a global provider of advanced diagnostic products, today reported net sales for the fiscal year 2017 were $5,791,670 versus net sales of $5,139,816 in fiscal 2016, an... 
From GlobeNewswire News Releases
Biomerica Announces Point of Care Product Distribution Agreement with a Multinational Pharmaceutical Company
Biomerica, Inc. (Nasdaq:BMRA) announced today a distribution agreement to supply one of its point of care products to a multinational pharmaceutical company for distribution in Mexico. 
From GlobeNewswire News Releases
Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017
From Marketwired News Releases
Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months
From Marketwired News Releases
Biomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter
From Marketwired News Releases
Biomerica to Present at the 9th Annual LD Micro Main Event
From ACCESSWIRE
Biomerica Announces First Quarter Fiscal 2017 Financial Results, Sales Increase Over Prior Year
From Marketwired News Releases
Biomerica Highlights Recent Scientific Reports Indicating Increased Prevalence of IBS
Company Emphasizes Its Goal of Guided Dietary Treatment as Irritable Bowel Syndrome Patients Continue to Seek Options to Improve Quality of Life 
From Marketwired News Releases
Biomerica to Present at 18th Annual Rodman & Renshaw Global Investment Conference
From Marketwired News Releases
Biomerica Announces Year End Results
From Marketwired News Releases
Biomerica Approved for Listing on the Nasdaq Capital Market
Company to Begin Trading on Nasdaq on August 26, 2016: Shares Will Trade as BMRA 
From Marketwired News Releases
Biomerica Updates Shareholders on Progress of Commercialization of Its New IBS Product
From Marketwired News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account